APA

Jacquillat C., Weil M., Auclerc G., Desprez-Curely J. P., Chastang C., Garçon C., Chantalou J. P., Gemon-Auclerc M. F., Delobel J., Dana M., Tanzer J., Teillet F., Izrael V., Chelloul N., Weisgerber C., De Heaulme M., Boiron M. & Bernard J. (19760324). Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up). : European journal of cancer.

Chicago

Jacquillat C, Weil M, Auclerc G, Desprez-Curely J P, Chastang C, Garçon C, Chantalou J P, Gemon-Auclerc M F, Delobel J, Dana M, Tanzer J, Teillet F, Izrael V, Chelloul N, Weisgerber C, De Heaulme M, Boiron M and Bernard J. 19760324. Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up). : European journal of cancer.

Harvard

Jacquillat C., Weil M., Auclerc G., Desprez-Curely J. P., Chastang C., Garçon C., Chantalou J. P., Gemon-Auclerc M. F., Delobel J., Dana M., Tanzer J., Teillet F., Izrael V., Chelloul N., Weisgerber C., De Heaulme M., Boiron M. and Bernard J. (19760324). Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up). : European journal of cancer.

MLA

Jacquillat C, Weil M, Auclerc G, Desprez-Curely J P, Chastang C, Garçon C, Chantalou J P, Gemon-Auclerc M F, Delobel J, Dana M, Tanzer J, Teillet F, Izrael V, Chelloul N, Weisgerber C, De Heaulme M, Boiron M and Bernard J. Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up). : European journal of cancer. 19760324.